Forum Discussion
Two steps forward, one step back – news on access to CDKs in second line treatment
Hello everyone,
BCNA has an update on access to CDKs as
second line treatment. Pfizer have this week advised BCNA about a new capped access
program for the CDK inhibitor palbociclib (lbrance) wh...
Hi @scientist, it is best to discuss this with your oncologist.
@primek, it is on announcements.
Cheers!
@primek, it is on announcements.
Cheers!